Badania kliniczne, które rekrutują lub wkrótce zaczną rekrutację w ośrodkach w mieście Kraków. Najwięcej badań dotyczy: chłoniak, nieswoiste zapalenia jelit, białaczka, rak płuca.
739 badań: 696 rekrutuje, 43 wkrótce zaczną.
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
+15Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
+4A Study of LAD603 in Adults With Alopecia Areata
Posttraumatic Stress Disorder in Ectopic Pregnancy
Post-traumatic Stress Disorder in Spontaneous Abortion
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
+7A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
+31Donidalorsen Treatment in Children With Hereditary Angioedema
The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.
Confirmatory Clinical Study in Active Ulcerative Colitis
+1ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
+6ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a…
+2Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
+14Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
+1A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
+14Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
+4Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
+3Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
+20A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
+7A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple…
+4Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic…
+9A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
+9Pregnancy and Fibrin Clot Properties
Impact of Different Electrical Frequencies Used in Percutaneous Neuromodulation on Muscle Strength and Pressure Pain Thresholds
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic…
Zadzwoń i porozmawiaj z doradcą ds. badań klinicznych. Sprawdzimy w rejestrach, do których badań możesz się kwalifikować.
Nie udzielamy porad ani konsultacji medycznych. Pomagamy znaleźć badanie i skontaktować się z ośrodkiem.
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 2 października 2026.